Logo

Heart to Heart Mission

For more than 20 years, the IPA has performed life-saving heart surgery on over 400 patients in Santiago, Dominican Republic.

Logo

Honduras Mission

The IPA is working with Duke to expand their heart surgery mission program in Honduras. We have a mission trip planned for mid-May. Stay tuned for more information.

Logo

Your Mission Trip

The IPA will gladly make donations to qualified charitable organizations who perform cardiac surgery mission work for patients in need.

600+

Patients served

Help Mend a Heart!

Every member of our team is an unpaid volunteer, so please take comfort in knowing that 100% of all donated funds go directly to patient care. Your generosity is so very welcome and will help save lives!

— Latest News —

Pulsatile Ventricular Assist Device (PulseCath)

Clinical and Preclinical Evidence on a Novel Percutaneous Pulsatile Ventricular Assist Device (PulseCath): Protocol for a Scoping Review

This protocol outlines a scoping review to explore the clinical and preclinical applications of PulseCath, a novel percutaneous pulsatile ventricular assist device. Designed to bridge the gap between intra-aortic balloon pumps and Impella systems, PulseCath offers intermediate support for patients with hemodynamic instability. The review will systematically evaluate its hemodynamic effects, pathophysiological basis, and safety profile.

READ MORE
Understanding Del Nido Cardioplegia

Del Nido Cardioplegia in Adult Cardiac Surgery: A Narrative Review

This review explores the use of Del Nido cardioplegia in adult cardiac surgery, originally developed for pediatric use. It outlines its composition, benefits over traditional blood cardioplegia, and its mechanism in protecting the myocardium from ischemia-reperfusion injury. The article compiles data showing its efficacy in reducing cross-clamp times, myocardial injury, and transfusion requirements, with comparable or improved clinical outcomes.

READ MORE

Revolutionizing Cardiovascular Interventions With Artificial Intelligence

This editorial outlines how artificial intelligence (AI) is transforming cardiovascular interventions by enhancing procedural planning, democratizing medical expertise, and expediting device development. AI-driven tools improve diagnostic accuracy, support training via simulation, and enable the creation of digital twins for personalized treatment planning. The article emphasizes AI’s potential to foster global equity in healthcare access and improve patient outcomes.

READ MORE